Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Antonie Van Leeuwenhoek ; 111(9): 1661-1672, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-29488182

RESUMO

The alcoholic fermentation for fuel ethanol production in Brazil occurs in the presence of several microorganisms present with the starter strain of Saccharomyces cerevisiae in sugarcane musts. It is expected that a multitude of microbial interactions may exist and impact on the fermentation yield. The yeast Dekkera bruxellensis and the bacterium Lactobacillus fermentum are important and frequent contaminants of industrial processes, although reports on the effects of both microorganisms simultaneously in ethanolic fermentation are scarce. The aim of this work was to determine the effects and interactions of both contaminants on the ethanolic fermentation carried out by the industrial yeast S. cerevisiae PE-2 in two different feedstocks (sugarcane juice and molasses) by running multiple batch fermentations with the starter yeast in pure or co-cultures with D. bruxellensis and/or L. fermentum. The fermentations contaminated with D. bruxellensis or L. fermentum or both together resulted in a lower average yield of ethanol, but it was higher in molasses than that of sugarcane juice. The decrease in the CFU number of S. cerevisiae was verified only in co-cultures with both D. bruxellensis and L. fermentum concomitant with higher residual sucrose concentration, lower glycerol and organic acid production in spite of a high reduction in the medium pH in both feedstocks. The growth of D. bruxellensis was stimulated in the presence of L. fermentum resulting in a more pronounced effect on the fermentation parameters than the effects of contamination by each microorganism individually.


Assuntos
Biocombustíveis/microbiologia , Dekkera/metabolismo , Etanol , Fermentação , Microbiologia Industrial , Limosilactobacillus fermentum/metabolismo , Saccharomyces cerevisiae/metabolismo , Ácido Acético , Brasil , Contagem de Células , Técnicas de Cocultura , Dekkera/crescimento & desenvolvimento , Glicerol , Concentração de Íons de Hidrogênio , Limosilactobacillus fermentum/crescimento & desenvolvimento , Interações Microbianas , Melaço , Saccharomyces cerevisiae/crescimento & desenvolvimento , Saccharum/metabolismo , Saccharum/microbiologia , Sacarose
2.
Int J Nanomedicine ; 16: 925-939, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33603360

RESUMO

BACKGROUND: Antimicrobial resistance poses substantial risks to human health. Thus, there is an urgent need for novel antimicrobial agents, including alternative compounds, such as peptides derived from bacterial toxin-antitoxin (TA) systems. ParELC3 is a synthetic peptide derived from the ParE toxin reported to be a good inhibitor of bacterial topoisomerases and is therefore a potential antibacterial agent. However, ParELC3 is inactive against bacteria due to its inability to cross the bacterial membranes. To circumvent this limitation we prepared and used rhamnolipid-based liposomes to carry and facilitate the passage of ParELC3 through the bacterial membrane to reach its intracellular target - the topoisomerases. METHODS AND RESULTS: Small unilamellar liposome vesicles were prepared by sonication from three formulations that included 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine and cholesterol. ParELC3 was loaded with high efficiency into the liposomes. Characterization by DLS and TEM revealed the appropriate size, zeta potential, polydispersity index, and morphology. In vitro microbiological experiments showed that ParELC3 loaded-liposomes are more efficient (29 to 11 µmol·L-1) compared to the free peptide (>100 µmol·L-1) at inhibiting the growth of standard E. coli and S. aureus strains. RL liposomes showed high hemolytic activity but when prepared with POPC and Chol this activity had a significant reduction. Independently of the formulation, the vesicles had no detectable cytotoxicity to HepG2 cells, even at the highest concentrations tested (1.3 mmol·L-1 and 50 µmol·L-1 for rhamnolipid and ParELC3, respectively). CONCLUSION: The present findings suggest the potential use of rhamnolipid-based liposomes as nanocarrier systems to enhance the bioactivity of peptides.


Assuntos
Antibacterianos/farmacologia , Portadores de Fármacos/química , Glicolipídeos/química , Nanopartículas/química , Peptídeos/farmacologia , Sistemas Toxina-Antitoxina , Sequência de Aminoácidos , Permeabilidade da Membrana Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Liberação Controlada de Fármacos , Difusão Dinâmica da Luz , Escherichia coli/efeitos dos fármacos , Hemólise/efeitos dos fármacos , Células Hep G2 , Humanos , Hidrodinâmica , Lipossomos , Testes de Sensibilidade Microbiana , Peptídeos/química , Sonicação , Staphylococcus aureus/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa